Clinical trials recruiting for Adult Congenital Heart Disease
4
Recruiting trials
5
US states with sites
5
Countries
25%
Accept healthy volunteers
Phase breakdown
Phase 4 1Not applicable 3
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Empagliflozin 10 MG | 1 |
| SGLT2 inhibitors | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Maryland | 1 |
| Michigan | 1 |
| New York | 1 |
| Ohio | 1 |
| Pennsylvania | 1 |
Top cities
Baltimore, Maryland 1Cincinnati, Ohio 1Grand Rapids, Michigan 1New York, New York 1Pittsburgh, Pennsylvania 1
Self-screener
Recruiting trials
- Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry
- Efficacy Of Sodium Glucose Transporter Inhibitor (SGLT2I) In Adult Patients With Congenital Heart Disease
- Heart Institute Biobank & Registry for Adult Congenital Heart Disease and Related Disorders
- Real-World Data on the Effects of Cardiac Resynchronization Therapy in Adult Patients With Congenital Heart Disease
Related conditions
Trials recruiting for Adult Congenital Heart Disease often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Adult Congenital Heart Disease trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.